differences compared with placebo or indicated statin are based on differences ... studies (over 1–2 years) at ezetimibe levels substantially higher than the maximum concentration of a ...

Now an analysis of clinical trials in more than 10,000 patients treated with a fortnightly or monthly injection of a PCSK9 inhibitors suggests they are just as safe as statins and ezetimibe ...

Ezetimibe reduces LDL cholesterol levels, and niacin raises HDL cholesterol levels; however, no previous studies have described the use of these two drugs in combination.